SecSonar.com

CONMED Corporation (CNMD)

CONMED Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CONMED Corporation (CNMD) is a Medical - Devices company based in US with a market capitalization of $1.1B. Revenue grew 5.2% year-over-year and the company generated $150.9M in free cash flow. This page tracks CNMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3.9K employees · IPO Jul 23, 1987

Valuation

Valuation & price

$35.49 · as of May 17, 2026 · -36.4% vs 52w high

23.5

P/E ratio

Latest-FY diluted EPS

1.04

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$55.19$43.65$32.11Jul 25Dec 25Jul 26Jul 7, 25$51.93Jul 9, 25$52.91Jul 11, 25$51.27Jul 15, 25$48.80Jul 17, 25$49.25Jul 21, 25$47.84Jul 23, 25$50.19Jul 25, 25$50.95Jul 29, 25$50.29Jul 31, 25$51.15Aug 4, 25$53.48Aug 6, 25$51.06Aug 11, 25$52.48Aug 13, 25$55.19Aug 15, 25$53.12Aug 19, 25$54.50Aug 21, 25$53.07Aug 25, 25$54.28Aug 27, 25$54.43Aug 29, 25$54.36Sep 3, 25$52.87Sep 5, 25$54.97Sep 9, 25$53.98Sep 11, 25$54.05Sep 16, 25$52.74Sep 18, 25$51.42Sep 22, 25$50.00Sep 24, 25$48.51Sep 26, 25$46.00Sep 30, 25$47.03Oct 2, 25$46.60Oct 6, 25$46.47Oct 8, 25$46.52Oct 10, 25$42.68Oct 14, 25$44.53Oct 16, 25$44.96Oct 21, 25$48.37Oct 23, 25$48.26Oct 27, 25$47.36Oct 29, 25$46.71Oct 31, 25$44.00Nov 4, 25$45.71Nov 6, 25$44.21Nov 10, 25$43.95Nov 12, 25$43.56Nov 14, 25$42.04Nov 18, 25$41.84Nov 20, 25$40.63Nov 25, 25$43.26Nov 28, 25$43.42Dec 2, 25$44.03Dec 4, 25$44.24Dec 8, 25$40.57Dec 10, 25$39.04Dec 12, 25$40.83Dec 16, 25$39.20Dec 18, 25$40.39Dec 22, 25$40.04Dec 24, 25$40.17Dec 29, 25$41.48Jan 2, 26$40.52Jan 6, 26$43.49Jan 8, 26$44.20Jan 12, 26$43.46Jan 14, 26$41.58Jan 16, 26$41.57Jan 21, 26$41.56Jan 23, 26$41.63Jan 27, 26$39.58Jan 29, 26$37.31Feb 2, 26$39.21Feb 4, 26$39.93Feb 9, 26$41.67Feb 11, 26$42.33Feb 13, 26$41.80Feb 18, 26$44.22Feb 20, 26$45.14Feb 24, 26$46.06Feb 26, 26$45.87Mar 2, 26$45.79Mar 4, 26$42.99Mar 6, 26$39.90Mar 10, 26$38.46Mar 12, 26$36.73Mar 17, 26$37.34Mar 19, 26$36.80Mar 23, 26$36.63Mar 25, 26$37.08Mar 27, 26$34.58Mar 31, 26$35.36Apr 2, 26$34.79Apr 7, 26$34.54Apr 9, 26$36.93Apr 13, 26$38.46Apr 15, 26$39.44Apr 17, 26$39.08Apr 22, 26$38.49Apr 24, 26$38.34Apr 28, 26$36.79Apr 30, 26$36.66May 4, 26$35.88May 6, 26$37.32May 8, 26$36.76May 12, 26$35.97May 14, 26$36.34May 18, 26$36.61May 20, 26$37.01May 22, 26$37.23May 28, 26$35.52Jun 1, 26$34.65Jun 3, 26$33.06Jun 5, 26$35.16Jun 9, 26$36.90Jun 11, 26$34.41Jun 15, 26$34.16Jun 17, 26$32.11Jun 22, 26$32.54Jun 24, 26$35.40Jun 26, 26$35.95Jul 2, 26$33.83
$32.1152-week range$55.81
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

5.2%

Revenue growth (YoY)

52.8%

Gross margin

$150.9M

Free cash flow (USD)

$794.1M

Net debt

0.6%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$763.5MFY 2017$796.4MFY 2018$859.6MFY 2019$955.1MFY 2020$862.5MFY 2021$1.0BFY 2022$1.0BFY 2023$1.2BFY 2024$1.3BFY 2025$1.4B
$763.5M$1.4B

Free cash flow by year

2016 → 2025

FY 2016$23.5MFY 2017$52.7MFY 2018$58.2MFY 2019$75.1MFY 2020$51.5MFY 2021$96.9MFY 2022$11.6MFY 2023$106.3MFY 2024$153.9MFY 2025$150.9M
$23.5M$150.9M

Gross margin by year

2021 → 2025

FY 202156.2%FY 202254.6%FY 202354.3%FY 202456.1%FY 202552.8%
56.2%52.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCFO AppointmentJun 17, 2026Filing
  • 8-K eventDebt Purchase AgreementJun 4, 2026Filing
  • 8-K eventDebt RefinancingJun 1, 2026Filing
  • 8-K eventBy-Law AmendmentMay 20, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing

Questions

Frequently asked questions

What is CONMED Corporation's market cap?

CONMED Corporation (CNMD) has a market capitalization of $1.1B.

What is CNMD's P/E ratio?

CNMD trades at a price-to-earnings ratio of 23.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is CNMD's price-to-book (P/B) ratio?

CNMD trades at 1.04 times book value per share.

Are insiders buying CNMD stock?

SEC Form 4 filings show no open-market insider buys at CONMED Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

AORT

Artivion, Inc.

$1.1B

BFLY

Butterfly Network, Inc.

$1.2B

AVNS

Avanos Medical, Inc.

$1.2B

TNDM

Tandem Diabetes Care, Inc.

$1.2B

IRMD

IRadimed Corporation

$1.2B

ATEC

Alphatec Holdings, Inc.

$1.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.